Australian Pharmaceutical Industries Limited (API) - Financial and Strategic SWOT Analysis Review

Date: December 22, 2014
Pages: 35
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: AF99E3B944CEN
Leaflet:

Download PDF Leaflet

Australian Pharmaceutical Industries Limited (API) - Financial and Strategic SWOT Analysis Review
Australian Pharmaceutical Industries Limited (API) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Australian Pharmaceutical Industries Limited (API) is beauty and health retail company. It distributes pharmaceuticals, beauty, and health products through wholesale and retail channels. The company owns, operates, and franchises retail stores under the names, Priceline, and Priceline Pharmacy. Major products offered by API include skincare products, haircare products, cosmetics, over-the-counter (OTC) pharmaceuticals, and domestic products. Besides, it offers services such as wholesale product delivery, marketing programs, retail services, and business advisory services to independent pharmacies. The company operates a retail store network of 390 stores across Australia and New Zealand. API is headquartered in Camellia, New South Wales, Australia.

The company intends to increase the franchising activities of its Priceline Pharmacy stores thereby contributing to the growth of integrated dispensary and retail operations.

Australian Pharmaceutical Industries Limited Key Recent Developments

Sep 03, 2014: API FY14 Results Update
May 15, 2014: Australian Pharmaceutical Industries Limited - Appointment of Non-Executive Director

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Australian Pharmaceutical Industries Limited - Key Facts
Australian Pharmaceutical Industries Limited - Key Employees
Australian Pharmaceutical Industries Limited - Key Employee Biographies
Australian Pharmaceutical Industries Limited - Major Products and Services
Australian Pharmaceutical Industries Limited - History
Australian Pharmaceutical Industries Limited - Company Statement
Australian Pharmaceutical Industries Limited - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Australian Pharmaceutical Industries Limited - Business Description
Australian Pharmaceutical Industries Limited - Corporate Strategy
Australian Pharmaceutical Industries Limited - SWOT Analysis
SWOT Analysis - Overview
Australian Pharmaceutical Industries Limited - Strengths
Strength - Brand Image
Strength - Business Operations
Strength - Sound Profitability Indicators
Australian Pharmaceutical Industries Limited - Weaknesses
Weakness - Current Asset Turnover
Australian Pharmaceutical Industries Limited - Opportunities
Opportunity - Growth Prospects: Online Retail
Opportunity - Market Potential: Healthcare and Pharmaceutical
Opportunity - Key Business Initiatives
Australian Pharmaceutical Industries Limited - Threats
Threat - Competitive Landscape
Threat - Product Liability Claims
Threat - Stringent Regulations
Australian Pharmaceutical Industries Limited - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Australian Pharmaceutical Industries Limited, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Sep 03, 2014: API FY14 Results Update
May 15, 2014: Australian Pharmaceutical Industries Limited - Appointment of Non-Executive Director

SECTION 5 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Australian Pharmaceutical Industries Limited, Key Facts
Australian Pharmaceutical Industries Limited, Key Employees
Australian Pharmaceutical Industries Limited, Key Employee Biographies
Australian Pharmaceutical Industries Limited, Major Products and Services
Australian Pharmaceutical Industries Limited, History
Australian Pharmaceutical Industries Limited, Other Locations
Australian Pharmaceutical Industries Limited, Subsidiaries
Australian Pharmaceutical Industries Limited, Key Competitors
Australian Pharmaceutical Industries Limited, Ratios based on current share price
Australian Pharmaceutical Industries Limited, Annual Ratios
Australian Pharmaceutical Industries Limited, Interim Ratios
Australian Pharmaceutical Industries Limited, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Australian Pharmaceutical Industries Limited, Performance Chart (2010 - 2014)
Australian Pharmaceutical Industries Limited, Ratio Charts
Skip to top


Ask Your Question

Australian Pharmaceutical Industries Limited (API) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: